Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026)

Zimmer Biomet Holdings (ZBH) recorded quarterly Total Non-Current Liabilities of $9.4 billion in Q1 2026, down 3.59% quarter-over-quarter from $9.8 billion in Q4 2025, and down 2.42% on a YoY basis from $9.6 billion in Q1 2025.

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.4 billion for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 2.42% year-over-year to $9.4 billion; the TTM figure through Mar 2026 stood at $9.4 billion (down 2.42% YoY), while the FY2025 annual figure was $9.8 billion, up 12.07% from the prior year.
  • Total Non-Current Liabilities was $9.4 billion for Q1 2026 at Zimmer Biomet Holdings, down from $9.8 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $9.9 billion in Q3 2025 to a low of $7.6 billion in Q2 2024.
  • Historically, Total Non-Current Liabilities has averaged $8.7 billion across 5 years, with a median of $8.5 billion in 2022.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities retreated 20.99% in 2022, then rose 24.94% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $8.4 billion in 2022, then declined by 3.85% to $8.1 billion in 2023, then grew by 7.74% to $8.7 billion in 2024, then grew by 12.07% to $9.8 billion in 2025, then declined by 3.59% to $9.4 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $9.4 billion (Q1 2026), $9.8 billion (Q4 2025), and $9.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 20.94 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 24.21 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 3.47 Bn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 9.41 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.41 Bn
Dec 31, 2025 9.76 Bn
Sep 30, 2025 9.92 Bn
Jun 30, 2025 9.45 Bn
Mar 31, 2025 9.64 Bn
Dec 31, 2024 8.71 Bn
Sep 30, 2024 8.31 Bn
Jun 30, 2024 7.57 Bn
Mar 31, 2024 8.27 Bn
Dec 31, 2023 8.08 Bn
Sep 30, 2023 8.07 Bn
Jun 30, 2023 8.27 Bn
Mar 31, 2023 8.45 Bn
Dec 31, 2022 8.41 Bn
Sep 30, 2022 8.50 Bn
Jun 30, 2022 8.74 Bn
Mar 31, 2022 9.00 Bn
Dec 31, 2021 10.24 Bn
Sep 30, 2021 10.69 Bn
Jun 30, 2021 11.06 Bn